Mathew, S. O., Chaudhary, P., Powers, S. B., Vishwanatha, J. K., & Mathew, P. A. (2016). Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction. Oncotarget.
Chicago Style CitationMathew, Stephen O., Pankaj Chaudhary, Sheila B. Powers, Jamboor K. Vishwanatha, i Porunelloor A. Mathew. "Overexpression of LLT1 (OCIL, CLEC2D) On Prostate Cancer Cells Inhibits NK Cell-mediated Killing Through LLT1-NKRP1A (CD161) Interaction." Oncotarget 2016.
Cita MLAMathew, Stephen O., et al. "Overexpression of LLT1 (OCIL, CLEC2D) On Prostate Cancer Cells Inhibits NK Cell-mediated Killing Through LLT1-NKRP1A (CD161) Interaction." Oncotarget 2016.
Atenció: Aquestes cites poden no estar 100% correctes.